Literature DB >> 18164752

A test of the catecholamines hypothesis for an acute exercise-cognition interaction.

T McMorris1, K Collard, J Corbett, M Dicks, J P Swain.   

Abstract

The purpose of the study was to examine the usage of norepinephrine (NE) and dopamine (DA) in the brain when exercising while simultaneously undertaking cognitive tests. Plasma concentrations of the NE metabolite 3-methoxy 4-hydroxyphenylglycol (MHPG) and the DA metabolite homovanillic acid (HVA) showed a linear increase from rest to exercising at 40% and 80% maximum power output (W.max) while simultaneously undertaking cognitive tasks (random number generation (RNG) and response time). Delta plasma concentrations of MHPG and HVA at each exercise intensity while undertaking cognitive tasks and while exercising without cognitive tasks did not differ. Taking blood samples at 0, 1, 3, and 5 min following cessation of exercise did not affect results. Regression correlations showed that delta MHPG and HVA plasma concentrations at the 1 and 3 min sampling times were strong predictors of delta RNG, response time and movement time. Reaction time at 80% W.max significantly increased, while movement time at 80% W.max significantly decreased. It was concluded that these results provide no support for a direct effect of increased catecholamines concentrations on cognitive performance during exercise. The regression data suggest that there is some relationship between exercise, catecholamines concentrations and cognition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164752     DOI: 10.1016/j.pbb.2007.11.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  33 in total

1.  The relationship between school performance and the number of physical education classes attended by korean adolescent students.

Authors:  Sang-Yeob Kim; Wi-Young So
Journal:  J Sports Sci Med       Date:  2012-06-01       Impact factor: 2.988

2.  Effects of Physical Activity on Children's Executive Function: Contributions of Experimental Research on Aerobic Exercise.

Authors:  John R Best
Journal:  Dev Rev       Date:  2010-12

3.  Does cerebral oxygenation affect cognitive function during exercise?

Authors:  Soichi Ando; Masahiro Kokubu; Yosuke Yamada; Misaka Kimura
Journal:  Eur J Appl Physiol       Date:  2011-01-20       Impact factor: 3.078

4.  Cognitive functioning in midlife and old age: combined effects of psychosocial and behavioral factors.

Authors:  Stefan Agrigoroaei; Margie E Lachman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

5.  The Immediate Effects of Acute Aerobic Exercise on Cognition in Healthy Older Adults: A Systematic Review.

Authors:  Marie-Pier McSween; Jeff S Coombes; Christopher P MacKay; Amy D Rodriguez; Kirk I Erickson; David A Copland; Katie L McMahon
Journal:  Sports Med       Date:  2019-01       Impact factor: 11.136

6.  Visual threat detection during moderate- and high-intensity exercise.

Authors:  Morgan R Shields; Christine L Larson; Ann M Swartz; J Carson Smith
Journal:  Emotion       Date:  2011-06

7.  Feasibility of a 6-month exercise and recreation program to improve executive functioning and memory in individuals with chronic stroke.

Authors:  Debbie Rand; Janice J Eng; Teresa Liu-Ambrose; Amira E Tawashy
Journal:  Neurorehabil Neural Repair       Date:  2010-05-11       Impact factor: 3.919

Review 8.  Effects of cardiovascular exercise early after stroke: systematic review and meta-analysis.

Authors:  Oliver Stoller; Eling D de Bruin; Ruud H Knols; Kenneth J Hunt
Journal:  BMC Neurol       Date:  2012-06-22       Impact factor: 2.474

9.  Association between physical activity and academic performance in Korean adolescent students.

Authors:  Wi-Young So
Journal:  BMC Public Health       Date:  2012-04-02       Impact factor: 3.295

10.  Association between Physical Inactivity and Academic Record in Korean Adolescents.

Authors:  Yi-Soo Shin; Wi-Young So
Journal:  Iran J Public Health       Date:  2012-10-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.